178 related articles for article (PubMed ID: 19148629)
21. In vitro dissolution behaviour and absorption in humans of a novel mixed l-lysine salt formulation of EPA and DHA.
Manusama K; Balvers M; Diepeveen-de Bruin M; Headley L; Bosi R; Schwarm M; Witkamp R
Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102232. PubMed ID: 33360684
[TBL] [Abstract][Full Text] [Related]
22. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
Bryhn M; Hansteen H; Schanche T; Aakre SE
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):19-24. PubMed ID: 16806871
[TBL] [Abstract][Full Text] [Related]
23. Acute appearance of fatty acids in human plasma--a comparative study between polar-lipid rich oil from the microalgae Nannochloropsis oculata and krill oil in healthy young males.
Kagan ML; West AL; Zante C; Calder PC
Lipids Health Dis; 2013 Jul; 12():102. PubMed ID: 23855409
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
[TBL] [Abstract][Full Text] [Related]
25. Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.
Browning LM; Walker CG; Mander AP; West AL; Gambell J; Madden J; Calder PC; Jebb SA
J Nutr; 2014 May; 144(5):667-72. PubMed ID: 24647395
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance.
Maki KC; Johns C; Harris WS; Puder M; Freedman SD; Thorsteinsson T; Daak A; Rabinowicz AL; Sancilio FD
Clin Ther; 2017 Mar; 39(3):652-658. PubMed ID: 28189365
[TBL] [Abstract][Full Text] [Related]
27. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids.
James MJ; Ursin VM; Cleland LG
Am J Clin Nutr; 2003 May; 77(5):1140-5. PubMed ID: 12716664
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
Salm P; Taylor PJ; Kostner K
Biomed Chromatogr; 2011 Jun; 25(6):652-9. PubMed ID: 20737653
[TBL] [Abstract][Full Text] [Related]
30. Fatty acids in plasma, white and red blood cells, and tissues after oral or intravenous administration of fish oil in rats.
Barros KV; Carvalho PO; Cassulino AP; Andrade I; West AL; Miles EA; Calder PC; Silveira VL
Clin Nutr; 2013 Dec; 32(6):993-8. PubMed ID: 23541913
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.
Arterburn LM; Oken HA; Hoffman JP; Bailey-Hall E; Chung G; Rom D; Hamersley J; McCarthy D
Lipids; 2007 Nov; 42(11):1011-24. PubMed ID: 17713804
[TBL] [Abstract][Full Text] [Related]
32. Circulating fatty acid profiles in response to three levels of dietary omega-3 fatty acid supplementation in horses.
King SS; Abughazaleh AA; Webel SK; Jones KL
J Anim Sci; 2008 May; 86(5):1114-23. PubMed ID: 18192545
[TBL] [Abstract][Full Text] [Related]
33. Changes in Bioavailability of Omega-3 (DHA) through Alpha-Tocopheryl Phosphate Mixture (TPM) after Oral Administration in Rats.
Libinaki R; Gavin PD
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28930161
[TBL] [Abstract][Full Text] [Related]
34. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
Krokan HE; Bjerve KS; Mørk E
Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations.
Marsen TA; Pollok M; Oette K; Baldamus CA
Prostaglandins Leukot Essent Fatty Acids; 1992 Jul; 46(3):191-6. PubMed ID: 1387231
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of 13C-DHA before and during fish-oil supplementation in healthy older individuals.
Plourde M; Chouinard-Watkins R; Rioux-Perreault C; Fortier M; Dang MT; Allard MJ; Tremblay-Mercier J; Zhang Y; Lawrence P; Vohl MC; Perron P; Lorrain D; Brenna JT; Cunnane SC
Am J Clin Nutr; 2014 Jul; 100(1):105-12. PubMed ID: 24829492
[TBL] [Abstract][Full Text] [Related]
37. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL; French CB; Baggerly CA; Harris WS
Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
[TBL] [Abstract][Full Text] [Related]
38. Single-Dose SDA-Rich Echium Oil Increases Plasma EPA, DPAn3, and DHA Concentrations.
Greupner T; Koch E; Kutzner L; Hahn A; Schebb NH; Schuchardt JP
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581725
[TBL] [Abstract][Full Text] [Related]
39. Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids.
Visioli F; Risé P; Barassi MC; Marangoni F; Galli C
Lipids; 2003 Apr; 38(4):415-8. PubMed ID: 12848287
[TBL] [Abstract][Full Text] [Related]
40. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers].
Beckermann B; Beneke M; Seitz I
Arzneimittelforschung; 1990 Jun; 40(6):700-4. PubMed ID: 2144420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
